Theophylline in Chronic Obstructive Pulmonary Disease

NCT00299858 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Theophylline

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]